Skip to content
Home - Thrombosis - Antithrombotics    

eCME - Continuing Medical Education (CME)

  Antithrombotics

There are three main classes ofThumbnail image of eCME Antithrombotics course
antithrombotic drugs - Anticoagulant drugs
Antiplatelet drugs, Thrombolytic or
fibrinolytic drugs. Anticoagulant and antiplatelet drugs inhibit the coagulation
process and can therefore be administered
acutely to prevent the initial formation of blood clots, or thrombi, in patients with recognised risk factors. Thrombolytic or fibrinolytic drugs act by dissolving existing thrombi or emboli and therefore only play a role in the acute treatment of thrombosis
.

This course provides an overview of the antithrombotic drugs currently available, the different classes of drugs, their properties, including their mechanisms of action and principle indications.

The tutorial is available as a global demo version accessed via the table below.  (Unregistered users have limited access to the global course content - to access the full version of the course please register.)

 Language Region Interactive Version Plain Text
 Alternative
 English Global View Antithrombotic Demoopens in a new window View text versionopens in a new window
AstraZeneca websites
Login
>
Search
Resources
For your patients
Page services
>
>
>
>
Site map